Jeffrey Edward Nelson
CIK: 0001943112
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Milestone Pharmaceuticals Inc.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Feb 2, 2026MIST
Milestone Pharmaceuticals Inc.
Award(A)DirectEmployee Stock Option (right to buy)
204K shares- - Feb 2, 2026MIST
Milestone Pharmaceuticals Inc.
Award(A)DirectRestricted Stock Unit
136K shares- - Feb 2, 2026MIST
Milestone Pharmaceuticals Inc.
Award(A)DirectEmployee Stock Option (right to buy)
204K shares- - Jan 26, 2026MIST
Milestone Pharmaceuticals Inc.
Exercise(M)Direct20.1K shares- - Jan 26, 2026MIST
Milestone Pharmaceuticals Inc.
Sale(S)Direct12.2K shares at avg. $1.93$24K - Dec 15, 2025MIST
Milestone Pharmaceuticals Inc.
Sale(S)Direct58K shares at avg. $2.32$135K - Dec 12, 2025MIST
Milestone Pharmaceuticals Inc.
Award(A)Direct100K shares- - Jan 27, 2025MIST
Milestone Pharmaceuticals Inc.
Award(A)DirectRestricted Stock Unit
80.4K shares- - Jan 27, 2025MIST
Milestone Pharmaceuticals Inc.
Award(A)DirectEmployee Stock Option (right to buy)
120.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 2, 2026 | MIST Milestone Pharmaceuticals Inc. | Award(A) Employee Stock Option (right to buy) | 204,000 | - | - | Direct |
| Feb 2, 2026 | MIST Milestone Pharmaceuticals Inc. | Award(A) Restricted Stock Unit | 136,000 | - | - | Direct |
| Feb 2, 2026 | MIST Milestone Pharmaceuticals Inc. | Award(A) Employee Stock Option (right to buy) | 204,000 | - | - | Direct |
| Jan 26, 2026 | MIST Milestone Pharmaceuticals Inc. | Exercise(M) | 20,100 | - | $0 | Direct |
| Jan 26, 2026 | MIST Milestone Pharmaceuticals Inc. | Sale(S) | 12,245 | $1.93 | $23,633 | Direct |
| Dec 15, 2025 | MIST Milestone Pharmaceuticals Inc. | Sale(S) | 58,007 | $2.32 | $134,576 | Direct |
| Dec 12, 2025 | MIST Milestone Pharmaceuticals Inc. | Award(A) | 100,000 | - | $0 | Direct |
| Jan 27, 2025 | MIST Milestone Pharmaceuticals Inc. | Award(A) Restricted Stock Unit | 80,400 | - | - | Direct |
| Jan 27, 2025 | MIST Milestone Pharmaceuticals Inc. | Award(A) Employee Stock Option (right to buy) | 120,600 | - | - | Direct |
1-9 of 9 transactions
About Nelson Jeffrey Edward
Nelson Jeffrey Edward (SEC CIK 0001943112) files insider reports with the SEC as Chief Operating Officer of Milestone Pharmaceuticals Inc. (MIST).
Signal8 holds 4 ownership filings by Nelson Jeffrey Edward, all Form 4s, filed between Jan 29, 2025 and Feb 5, 2026. Those filings report 9 transactions, from Jan 27, 2025 to Feb 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Nelson Jeffrey Edward's filings is in MONTREAL, A8.
Recent filings by Nelson Jeffrey Edward
- Feb 2, 2026: Grants or awards of MIST derivative securities (3 lines, Form 4, code A).
- Jan 26, 2026: Option exercise of MIST shares (Form 4, code M).
- Jan 26, 2026: Open-market sale of MIST shares (Form 4, code S).
- Dec 15, 2025: Open-market sale of MIST shares (Form 4, code S).
- Dec 12, 2025: Grant or award of MIST shares (Form 4, code A).
Other insiders filing for Milestone Pharmaceuticals Inc. (MIST)
- Giles Lisa M., Director
- Fischer Seth H. Z., Director
- Duty Stuart, Director
- Wills Robert James, Director
- TOMSICEK MICHAEL JOHN, Director
- Saik Andrew, Director